StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$390.30−6.39 (-1.61%)

Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%

West Pharmaceutical Services Contract Assets (Unbilled Revenue) by Quarter

Contract Assets (Unbilled Revenue) ($M)

West Pharmaceutical Services Contract Assets (Unbilled Revenue): $15.1M in Q3 2026, down 45.1% from a year earlier.

Latest, Q3 2026
15.1
Period ended Sep 30, 2026
Change on a year earlier
-45.1%
27.5 in Q3 2025
History
22 quarters
Since Q1 2019
Sources
22
Documents cited below

Where the Q3 2026 figure comes from

Source: West Form 10-Q (FY2026Q3, filed 2026-10-29) ↗

Reported in Form 10-K / 10-Q Note 3 (Revenue).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedContract Assets (Unbilled Revenue) ($M)Year on yearSource
Q3 2026Sep 30, 202615.1-45.1%West Form 10-Q (FY2026Q3, filed 2026-10-29) ↗
Q2 2026Jun 30, 202617.2-38.4%West Form 10-Q (FY2026Q2, filed 2026-07-23) ↗
Q1 2026Mar 31, 202615.4-40.3%West Form 10-Q (FY2026Q1, filed 2026-04-23) ↗
Q3 2025Sep 30, 202527.5-35.0%West Form 10-Q (FY2025Q3, filed 2025-10-23) ↗
Q2 2025Jun 30, 202527.9+23.5%West Form 10-Q (FY2025Q2, filed 2025-07-24) ↗
Q1 2025Mar 31, 202525.8+29.6%West Form 10-Q (FY2025Q1, filed 2025-04-24) ↗
Q3 2024Sep 30, 202442.3+112.6%West Form 10-Q (FY2024Q3, filed 2024-10-24) ↗
Q2 2024Jun 30, 202422.6+5.6%West Form 10-Q (FY2024Q2, filed 2024-07-25) ↗
Q1 2024Mar 31, 202419.9+2.6%West Form 10-Q (FY2024Q1, filed 2024-04-25) ↗
Q3 2023Sep 30, 202319.9+8.7%West Form 10-Q (FY2023Q3, filed 2023-10-26) ↗
Q2 2023Jun 30, 202321.4+44.6%West Form 10-Q (FY2023Q2, filed 2023-07-27) ↗
Q1 2023Mar 31, 202319.4+31.1%West Form 10-Q (FY2023Q1, filed 2023-04-27) ↗
Q3 2022Sep 30, 202218.3+43.0%West Form 10-Q (FY2022Q3, filed 2022-10-27) ↗
Q2 2022Jun 30, 202214.8+46.5%West Form 10-Q (FY2022Q2, filed 2022-07-28) ↗
Q1 2022Mar 31, 202214.8+18.4%West Form 10-Q (FY2022Q1, filed 2022-04-28) ↗
Q3 2021Sep 30, 202112.8-21.0%West Form 10-Q (FY2021Q3, filed 2021-10-28) ↗

Cite this data

StockData. (2026). West Pharmaceutical Services Contract Assets (Unbilled Revenue) ($M), quarterly Q1 2019–Q3 2026 [Data set]. Compiled from West Pharmaceutical Services SEC filings and investor materials. https://stockdatahq.com/stocks/wst/kpis/contract-assets

See every metric in the West Pharmaceutical Services KPI table. Data updated Nov 9, 2026.

See a number that looks wrong?